Treska V - Search Results

1

Searching for New Biomarkers and the Use of Multivariate Analysis in Gastric Cancer Diagnostics.

Kucera R, Smid D, Topolcan O, Karlikova M, Fiala O, Slouka D, Skalicky T, Treska V, Kulda V, Simanek V, Safanda M, Pesta M. Kucera R, et al. Among authors: treska v. Anticancer Res. 2016 Apr;36(4):1967-71. Anticancer Res. 2016. PMID: 27069188

2

Evaluation of tumour markers as differential diagnostic tool in patients with suspicion of liver metastases from breast cancer.

Liska V, Holubec L Jr, Treska V, Vrzalova J, Skalicky T, Sutnar A, Kormunda S, Bruha J, Vycital O, Finek J, Pesta M, Pecen L, Topolcan O. Liska V, et al. Among authors: treska v. Anticancer Res. 2011 Apr;31(4):1447-51. Anticancer Res. 2011. PMID: 21508401

3

Prognostic significance of TIMP-1 in non-small cell lung cancer.

Pesta M, Kulda V, Kucera R, Pesek M, Vrzalova J, Liska V, Pecen L, Treska V, Safranek J, Prazakova M, Vycital O, Bruha J, Holubec L, Topolcan O. Pesta M, et al. Among authors: treska v. Anticancer Res. 2011 Nov;31(11):4031-8. Anticancer Res. 2011. PMID: 22110238

4

Plasma TIMP1 level is a prognostic factor in patients with liver metastases.

Bunatova K, Pesta M, Kulda V, Topolcan O, Vrzalova J, Sutnar A, Treska V, Pecen L, Liska V. Bunatova K, et al. Among authors: treska v. Anticancer Res. 2012 Oct;32(10):4601-6. Anticancer Res. 2012. PMID: 23060593

5

Monitoring of circulating tumor cells in patients undergoing surgery for hepatic metastases from colorectal cancer.

Pesta M, Fichtl J, Kulda V, Topolcan O, Treska V. Pesta M, et al. Among authors: treska v. Anticancer Res. 2013 May;33(5):2239-43. Anticancer Res. 2013. PMID: 23645782

6

Evaluation of IL-2, IL-6, IL-8 and IL-10 in Malignant Melanoma Diagnostics.

Kucera R, Topolcan O, Treskova I, Kinkorova J, Windrichova J, Fuchsova R, Svobodova S, Treska V, Babuska V, Novak J, Smejkal J. Kucera R, et al. Among authors: treska v. Anticancer Res. 2015 Jun;35(6):3537-41. Anticancer Res. 2015. PMID: 26026122

7

The Role of TPS and TPA in the Diagnostics of Distant Metastases.

Kucera R, Topolcan O, Fiala O, Kinkorova J, Treska V, Zedníková I, Slouka D, Simanek V, Safanda M, Babuska V. Kucera R, et al. Among authors: treska v. Anticancer Res. 2016 Feb;36(2):773-7. Anticancer Res. 2016. PMID: 26851038

8

Circulating Growth and Angiogenic Factors and Lymph Node Status in Early-stage Breast Cancer - A Pilot Study.

Karlikova M, Topolcan O, Narsanska A, Kucera R, Treskova I, Treska V. Karlikova M, et al. Among authors: treska v. Anticancer Res. 2016 Aug;36(8):4209-14. Anticancer Res. 2016. PMID: 27466533

9

CEA, CA 15-3, and TPS as Prognostic Factors in the Follow-up Monitoring of Patients After Radical Surgery for Breast Cancer.

Svobodova S, Kucera R, Fiala O, Karlikova M, Narsanska A, Zedníková I, Treska V, Slouka D, Rousarova M, Topolcan O, Finek J. Svobodova S, et al. Among authors: treska v. Anticancer Res. 2018 Jan;38(1):465-469. doi: 10.21873/anticanres.12245. Anticancer Res. 2018. PMID: 29277810

10

Perioperative Tumour Marker Levels as Prognostic Factors for Surgical Treatment of Breast Cancer Liver Metastases.

Treska V, Topolcan O, Zoubkova V, Treskova I, Narsanska A, Kucera R. Treska V, et al. Anticancer Res. 2018 Jun;38(6):3647-3652. doi: 10.21873/anticanres.12640. Anticancer Res. 2018. PMID: 29848722

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

394 results

Search Page